CIK 0000318154
- Large accelerated filer
AMGEN INC
Sign in to watch- Ticker
- AMGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 953540776
- Phone
- +1 805-447-1000
- Business address
- ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-19 | Kullman Ellen Jamison Director | Grant or award | +665 | 14,535.98 | ||
| 2025-05-23 | Kullman Ellen Jamison Director | Grant or award | +809 | 13,466.98 | ||
| 2024-05-31 | Kullman Ellen Jamison Director | Grant or award | +719 | 12,299.98 | ||
| 2023-05-19 | Kullman Ellen Jamison Director | Grant or award | +939 | 11,208.98 | ||
| 2022-11-08 | Kullman Ellen Jamison Director | Grant or award | +222.31 | 10,112.98 | ||
| 2022-08-09 | Kullman Ellen Jamison Director | Grant or award | +130.86 | 9,814.67 | ||
| 2022-05-17 | Kullman Ellen Jamison Director | Grant or award | +855 | 9,607.82 | ||
| 2022-05-02 | Kullman Ellen Jamison Director | Grant or award | +140.74 | 8,752.82 | ||
| 2021-11-05 | Kullman Ellen Jamison Director | Grant or award | +152.03 | 8,477.08 | ||
| 2021-08-06 | Kullman Ellen Jamison Director | Grant or award | +282.42 | 8,263.04 | ||
| 2021-05-18 | Kullman Ellen Jamison Director | Grant or award | +837 | 7,930.62 | ||
| 2021-04-30 | Kullman Ellen Jamison Director | Grant or award | +135.62 | 7,093.62 | ||
| 2021-02-05 | Kullman Ellen Jamison Director | Grant or award | +16.93 | 6,908 | ||
| 2020-11-02 | Kullman Ellen Jamison Director | Grant or award | +140.77 | 6,846.07 |
Page 1 of 1 · 14 trades